CO5140078A1 - Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina e histamina - Google Patents

Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina e histamina

Info

Publication number
CO5140078A1
CO5140078A1 CO99063416A CO99063416A CO5140078A1 CO 5140078 A1 CO5140078 A1 CO 5140078A1 CO 99063416 A CO99063416 A CO 99063416A CO 99063416 A CO99063416 A CO 99063416A CO 5140078 A1 CO5140078 A1 CO 5140078A1
Authority
CO
Colombia
Prior art keywords
neuroquinine
antagonis
tas
histamine
receivers
Prior art date
Application number
CO99063416A
Other languages
English (en)
Inventor
Robert G Aslanian
John J Piwinski
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO5140078A1 publication Critical patent/CO5140078A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica útil para el tratamiento de la rinitis alérgica, el asma y trastornos relacionados. En una realización, la composición comprende, en combinación, una cantidad terapéuticamente efectiva de al menos un antagonista de neuroquinina, una cantidad efectiva de al menos un antagonista H3 y una cantidad efectiva de al menos un antagonista H1.<EMI FILE="99063416_1" ID="1" IMF=JPEG >
CO99063416A 1998-10-09 1999-10-06 Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina e histamina CO5140078A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16960898A 1998-10-09 1998-10-09

Publications (1)

Publication Number Publication Date
CO5140078A1 true CO5140078A1 (es) 2002-03-22

Family

ID=22616405

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99063416A CO5140078A1 (es) 1998-10-09 1999-10-06 Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina e histamina

Country Status (10)

Country Link
EP (1) EP1117405A2 (es)
JP (1) JP2002527381A (es)
CN (1) CN1329490A (es)
AR (1) AR020740A1 (es)
AU (1) AU6252699A (es)
CA (1) CA2346227A1 (es)
CO (1) CO5140078A1 (es)
MY (1) MY130725A (es)
PE (1) PE20001097A1 (es)
WO (1) WO2000021512A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020324A1 (es) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
WO2004069338A1 (en) * 2003-01-31 2004-08-19 Schering Corporation Use of combinations of h1 and h3 histamine receptor antagonists for the preparation of a medicament for the treatment of allergic skin and allergic ocular conditions
BRPI0807972A2 (pt) 2007-01-24 2014-06-10 Glaxo Group Ltd Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
DE102012102417A1 (de) 2012-03-21 2013-09-26 Balluff Gmbh Identifikationssystem
EP3520803A1 (en) * 2018-01-31 2019-08-07 Zarodex Therapeutics Limited Novel uses
CN116496205A (zh) * 2022-05-06 2023-07-28 成都施贝康生物医药科技有限公司 一种卡瑞斯汀的盐及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310066D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Alkyl substituted heterocycles
CA2198084C (en) * 1994-08-25 2000-03-28 Timothy P. Burkholder Novel substituted piperidines useful for the treatment of allergic diseases
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
AR008293A1 (es) * 1996-08-16 1999-12-29 Schering Corp Composicion que comprende una cantidad antihistaminica para el tratamiento de las respuestas alergicas de las vias respiratorias superiores

Also Published As

Publication number Publication date
AU6252699A (en) 2000-05-01
WO2000021512A3 (en) 2000-07-06
EP1117405A2 (en) 2001-07-25
AR020740A1 (es) 2002-05-29
MY130725A (en) 2007-07-31
PE20001097A1 (es) 2000-10-31
JP2002527381A (ja) 2002-08-27
CA2346227A1 (en) 2000-04-20
WO2000021512A2 (en) 2000-04-20
CN1329490A (zh) 2002-01-02

Similar Documents

Publication Publication Date Title
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
DE60120372D1 (de) Verwendung von insulin zur behandlung von knorpelkrankheiten
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
WO2004019884A3 (en) Agents and methods for enhancing bone formation
BRPI0417376A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização
BR0314308A (pt) Composto, composição farmacêutica, métodos para bloquear uma combinação de mu, kappa, delta ou receptor (heterodìmero) dos mesmos em mamìferos, para tratar ou prevenir obesidade e doenças relacionadas, para suprimir o apetite em um paciente em necessidade deste, e para realizar a perda de peso em um paciente obeso, e, uso de um composto
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
ES2194057T3 (es) Inhibidor de proteasa de leucocitos de secrecion (slpi) como inhibidor de triptasa.
GT199700009AA (es) Terapia combinada para la osteoporosis
SE9804000D0 (sv) New composition of matter
WO2001064008A3 (en) Vaccine for the treatment of artherosclerosis
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
MY121054A (en) Calcilytic compounds as calcium receptor antagonists.
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
CO5140078A1 (es) Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina e histamina
ATE457177T1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
SE9900833D0 (sv) Novel combination
HU9503625D0 (en) Use of p antagonist for producing pharmaceutical compositions for treating acne, rosacea and/or pubic arythema
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
ATE309811T1 (de) Analgetikum aus schlangengift
CO5140080A1 (es) Composicion y metodo para tratar enfermedades alergicas dades respiratorias que comprende combinaciones de antagonis tas de receptores de neuroquinina y leucotrieno.
SE9900834D0 (sv) Novel combination
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas